Description

(Growth Hormone Secretagogue Blend for Anti-Aging, Recovery, and Lean Body Support)

Synergistic Peptide Therapy for Endogenous GH Optimization

CJC-1295 and Ipamorelin, delivered together in a high-potency 40 mg/mL injectable formulation, represent a cutting-edge, synergistic approach to stimulating natural growth hormone (GH) release. This compounded peptide blend, provided in a 6 mL multidose sterile vial, is designed for subcutaneous use under clinical supervision as part of anti-aging, body composition, and wellness optimization protocols.

By combining the GH-releasing hormone analog CJC-1295 with the GHRP (growth hormone-releasing peptide) Ipamorelin, this formulation provides both pulsatile and sustained GH stimulation—supporting improved sleep, recovery, lean mass development, skin health, and metabolic function.

Key Specifications

• Concentration: 40 mg/mL

• Volume: 6 mL multidose vial

• Total peptide content: 240 mg per vial (CJC + Ipamorelin combined)

• Administration: Subcutaneous injection

• Storage: Refrigerate at 2–8°C (36–46°F); do not freeze

• Use: Compounded for prescription use only

What Are CJC-1295 and Ipamorelin?

CJC-1295 is a GHRH analog that extends the half-life of natural growth hormone-releasing hormone through tetrasubstituted modifications and binding to albumin. It promotes longer-lasting, steady GH elevation without overstimulating cortisol or prolactin.

Ipamorelin is a selective growth hormone-releasing peptide (GHRP) that mimics ghrelin’s effect on the pituitary but without unwanted side effects like increased hunger, cortisol, or prolactin. It triggers quick, pulse-like GH release, aligning well with the slower, sustained mechanism of CJC-1295.

Together, these peptides create a dual-action pathway for natural, physiologic GH secretion, leading to enhanced cellular repair, lean tissue support, and metabolic renewal.

Mechanism of Action

• CJC-1295: Binds to GHRH receptors to increase GH pulse amplitude and duration

• Ipamorelin: Stimulates ghrelin receptors (GHS-R1a) to rapidly release GH from the pituitary

• Synergistic effect: Mimics natural GH secretion patterns, supporting regenerative processes and anabolic activity without disrupting normal hormone feedback loops

This combination promotes restorative GH release, particularly during sleep and post-exercise windows, enhancing overall body composition and recovery.

Clinical Applications

CJC/Ipamorelin therapy is widely used in functional, sports, and age-management medicine for:

• Anti-aging and wellness optimization

• Improved sleep quality and recovery

• Increased lean muscle and fat metabolism

• Support for skin elasticity and collagen production

• Enhanced energy, stamina, and libido

• Adjunct to hormone replacement therapy (HRT)

• Support for GH deficiency without direct hormone replacement

It is also used as a non-steroidal alternative for athletes and individuals seeking GH support without exogenous HGH administration.

Dosing and Administration

• Typical dose: 100–300 mcg daily, subcutaneously

• Timing: Most commonly dosed at bedtime to align with natural GH secretion

• Protocol: 5 days on / 2 days off (or as prescribed by a provider)

• Injection site: Subcutaneous tissue of the abdomen or thigh

Cycles often last 8–12 weeks, followed by re-evaluation of progress and biomarkers.

Safety and Tolerability

CJC/Ipamorelin is generally well-tolerated, with a significantly reduced risk of side effects compared to exogenous HGH therapy or first-generation GHRPs.

Possible mild side effects may include:

• Temporary redness or swelling at injection site

• Mild water retention

• Vivid dreams (due to deeper REM sleep)

• Transient headache or dizziness

Unlike other peptides, this blend does not stimulate prolactin, cortisol, or hunger, making it a clean option for long-term protocols.

Contraindications and Precautions

Not recommended for use in:

• Individuals with active or recent cancer

• Pregnant or breastfeeding individuals

• Patients with untreated endocrine disorders without supervision

Use with caution in:

• Diabetic or insulin-resistant patients

• Individuals on concurrent HRT

• Those with sensitivity to peptide-based products

Storage and Handling

• Store at 2–8°C (36–46°F)

• Protect from light

• Do not freeze

• Use within 30 days of first puncture

• Use aseptic technique for every withdrawal

Why Choose CJC/Ipamorelin?

• Synergistic dual-pathway GH stimulation

• Minimal side effect profile

• No impact on cortisol, prolactin, or hunger

• Supports both aesthetic and functional outcomes

• Integrates well with HRT, NAD+, and performance protocols

• Preferred by regenerative medicine practitioners worldwide

CJC-1295 / Ipamorelin 40 mg/mL – 6 mL Vial offers a powerful, clinically validated peptide solution for restoring youthful growth hormone patterns without hormonal suppression or anabolic risk. Ideal for those seeking improved recovery, sleep, fat loss, and anti-aging support, this formulation is a trusted component in personalized longevity and performance medicine.